Come explore with us at the 2023 SNMMI Therapeutics Conference. September 21-23 Find us in Booth #16 Regulatory guidance and support designed specifically for radiopharm More radiopharm open INDs and approved NDAs than anyone i...
Blogs
Facet By The Numbers – Q2 2023
FACET BY THE NUMBERS Total submissions to FDA April – June 2023: 35 (on average almost 3 submissions a week!) Early-stage development highlights: preparation/submission of 3 new INDs and submitted over 22 IND amendments (e.g.,...
FDA Round Up – Q2 2023
FDA ROUNDUP: FDA issues important draft guidance for developers of psychedelic drugs for potential treatment of medical conditions (June 23, 2023). Currently, there are hundreds of organizations across the world who are develo...
Did You Know – Q2 2023
DID YOU KNOW? Facet helps to develop products in every therapeutic area and has specialty expertise in ophthalmology, oncology, diagnostic/therapeutic radiopharmaceuticals, and controlled substances Facet’s scientific experts ...
Facet Life Sciences Team Focus – Q2 2023
Team FocusDr. Jason Mercer attended the annual Food and Drug Law Institute (FDLI) annual conference May 17-18 in Washington, DC. The FDLI annual conference addresses complex legal, regulatory, compliance, and policy issues fac...
Spotlight On – Q2 2023
RECENT FACET SUCCESSES – JUST A FEW HIGHLIGHTS ULTRA RARE DISEASE DEVELOPMENT: Facet helps growing start-up design a development plan for a pediatric ultra rare disease indication. A small ex-US company asked Facet to pro...
Facet Life Sciences Quarterly Update Q2 – 2023
RECENT FACET SUCCESSES – JUST A FEW HIGHLIGHTSULTRA RARE DISEASE DEVELOPMENT: Facet helps growing start-up design a development plan for a pediatric ultra rare disease indication. A small ex-US company asked Facet to provide US...
Facet Life Sciences Introduces Dynamic Careers Pages on Website
PRESS RELEASE FOR IMMEDIATE RELEASE Facet Life Sciences Introduces Dynamic Careers Pages on Website, Empowering Talent Acquisition and Enhancing Candidate Experience Phoenixville, PA, 7/18/2023 – Facet Life Sciences, a globally...
Facet Life Sciences Certified as Best Places to Work for 2023
Facet Life Sciences is excited to announce that we are now Great Places to Work Certified! This is an honor given to us by our employees and we couldn’t be prouder. 100% of employees at Facet Life Sciences say it is a great pl...
Facet By The Numbers – Q1 2023
FACET BY THE NUMBERS Total submissions to FDA January – March 2023: 41 (on average over 3 submissions a week!) Early-stage development highlights: preparation/submission of 7 new INDs and submitted over 20 IND amendments (e....
FDA Round Up – Q1 2023
FDA ROUNDUP: Rare Disease Day: On February 27, 2023, FDA hosted a virtual Rare Disease Day the purpose of which was to explore patient and patient advocate engagement in supporting the development of products for rare diseases...
Did You Know – Q1 2023
DID YOU KNOW? Facet only works with smaller life sciences companies, academic institutions, or nonprofit organizations to help get their products to and through FDA Facet was regulatory lead for two US marketing approvals in 2...
gET sOCIAL